Artificial Iris Market : Current Scenario and Forecast (2019-2025): Emphasis on Material Type (Fiber Artificial Iris, Fiber-free Artificial Iris), Colour (Blue Colour Artificial Iris, Brown Colour Artificial Iris, Other Colour), Application (Cosmetic, Therapeutic), Age Group (Pediatric, Adults), End-Users (Hospitals, Eye Surgery Centers, Others Eye Care Facility) and Region/Country
- UNI4065907
- 168 Pages
- February 2020
- Healthcare
“Amongst material type, Fibre-free artificial iris dominated the global market in 2018, accounting for 55.4% share”
Based on material type, the market has been divided into fibre and fibre free. In 2018, Fibre-free artificial iris dominated the market. Fibre model is composed of an embedded polyester meshwork layer to provide ample tear strength to withstand suturing whereas, the fibre-free model is suitable for sutureless implant techniques or can be sutured. Fibre artificial iris is expected to witness a CAGR growth of 7.01% during the analysed period.
“Adult cohorts are expected to dominate the age group during the forecast period 2019-2025”
In terms of the patient’s age, the market is divided into Paediatrics and adult cohorts. Paediatrics suffering from congenital aniridia can undergo the procedure for the correction of inborn disorder. In 2018, artificial iris implant was majorly performed on adults, which accounted for more than 90% of cases.
“Artificial Iris was majorly applied for Therapeutics application, followed by Cosmetic application”
Based on application, the market has been bifurcated into cosmetic and therapeutic. Cosmetic applications are for the patients who are self-conscious about the appearance of their eyes with an abnormal pupil. Therapeutic application of the artificial iris is for the patient suffering from traumatic iris defects. In 2018, Cosmetic application segment generated revenue of US$ 2.12 million. However, the Therapeutics application segment is expected to witness a CAGR growth of 6.28% during the analysed period.
“Blue colour iris dominated the market, followed by brown colour in 2018”
Based on colour, the global artificial iris market is bifurcated into brown iris and blue iris and other colour artificial iris. Blue colour dominated the market as it is highly preferred by the patients when undergone cosmetic surgery for the changing of eye colour. The brown colour artificial iris segment is expected to generate revenue of US$ 5.65 million by 2025.
“Amongst end-user, the hospital segment dominated the market in 2018, and is anticipated to dominate Global Artificial Iris market by 2025.”
Based on end-user, the global artificial iris market is segmented into hospitals, eye surgery centres and other end-user. Hospital segment dominated the market as it is one of the major institutions that offer healthcare services such as surgeries and prosthetic implantations. The segment is expected to witness a CAGR growth of 6.1% during the forecast period 2019-2025.
“In 2018, Europe was the largest market for Artificial Iris technology”
For a deep-dive analysis of the overall adoption and penetration of Artificial iris technology, detailed region/country level study was conducted for major region/county including North America (US, Canada, Rest of North America), Europe (Germany, Netherlands, Rest of Europe), Asia-Pacific (China, Japan, India and Rest of Asia-Pacific) and Rest of the World. In 2018, Europe represented as the highest revenue-generating region, accounting for 41% share, followed by North America and Asia-Pacific. Asia-Pacific is expected to witness a CAGR growth of 6.96% during the analyzed period 2019-2025.
Competitive Landscape-Top Market Players
Ophtec, HumanOptics AG, Morcher, ReperNN, VEO Ophthalmics, Spectrum Surgical, Eye-yon Medical and Pixium Vision are some of the prominent players operating in the Global Artificial Iris market. Several product launches, M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Reasons to buy:
• Current and future market size from 2018 to 2025 in terms of value (US$)
• Combined analysis of deep-dive secondary research and input from primary research through Key Opinion Leaders of the industry
• Country-level details of the overall adoption of Artificial Iris market
• A quick review of overall industry performance at a glance
• In-depth analysis of key industry players
• The current and projected scenario of the world's eyesight, techniques for artificial iris implantation and pipeline activity of devices
• A detailed analysis of drivers, restraints, key trends and opportunities prevailing in the industry
• Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start-ups
• The study comprehensively covers the market across different segments and sub-segments of the technology
• Region/country Covered: North America (US, Canada, Rest of North America), Europe (Germany, Netherlands, Rest of Europe), Asia-Pacific (China, Japan, India and Rest of Asia-Pacific) and Rest of the World
Customization Options:
UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Artificial Iris Market can be customized to the country level or any other market segment.
1.1 Market Definition 16
1.2 Objective of the Study 16
1.3 Limitation 16
1.4 Stakeholders 16
1.5 Currency used in the Report 17
1.6 Scope of the Global Artificial Iris Market Study 17
2. RESEARCH METHODOLOGY OR ASSUMPTION 18
2.1 Research Methodology for Global Artificial Iris Market Study 18
2.1.1 Main objective of the Artificial Iris Market Study 19
3. INDUSTRY PERFORMANCE 20
4. EXECUTIVE SUMMARY 22
5. CURRENT AND PROJECTED SCENARIO OF THE WORLD'S EYESIGHT 24
5.1 General Overview 24
5.1.1 Key Facts on the state of the world's eyesight 24
5.1.2 Improving the world’s Eyesight; the Goals of Vision 2020 28
6. MARKET OVERVIEW 30
6.1 Introduction 30
6.2 Market Dynamics 31
6.2.1 Market Drivers 31
6.2.1.1 Accelerating Geriatric Population 31
6.2.1.1.1 Some of the Key Facts regarding Ageing and health 31
6.2.1.2 Growing Number of Eye Defects 33
6.2.1.3 Increasing Demand of Minimally Invasive Surgical Procedures 34
6.2.1.4 Rising Healthcare Expenditure and Health-Conscious Personals 34
6.2.2 Market Restraints 38
6.2.2.1 Side Effects Associated with Implant Procedure 38
6.2.2.2 Lack of Reimbursement 38
6.2.2.3 Lack of Trained Professionals 39
6.2.3 Market Opportunities 39
6.2.3.1 Artificial Intelligence (AI) in Ophthalmology 39
7. TECHNIQUES FOR ARTIFICIAL IRIS IMPLANTATION 41
7.1 Overview 41
7.1.1 Surgical Techniques 41
7.1.2 Techniques 42
7.1.3 Sector- or Segment-Shaped Artificial Iris Sutured Side-by-Side to the Residual Iris 43
7.1.4 Injector-Assisted Sulcus-Fixated Complete Iris in Pseudophakic Eyes 43
7.1.5 Injector-Assisted Implantation of a Complete Iris in the Capsular Bag in Combination with Planned Standard Cataract Surgery 43
7.1.6 Complete Iris Prosthesis Implantation Sutured to the Sclera in Combination with a Scleral-Fixated Intraocular Lens in Aniridia and Aphakia of Vitrectomized Eyes 44
7.1.7 “Sandwich” or “Backpack” Iris Prosthesis Implantation in Combination with an Intraocular Lens in Aniridia and Aphakia 44
7.1.8 Open-Sky Implantation During a Perforating Keratoplasty 45
8. DEMAND AND SUPPLY SIDE ANALYSIS 46
8.1 Demand Side Analysis 46
8.2 Supply Side Analysis 47
8.2.1 Top Product Launch 48
8.2.2 Top Partnerships 48
8.2.3 Top Business Expansion & Investment 48
8.2.4 Value Chain Analysis of Artificial Iris 49
9. PIPELINE ACTIVITY 50
9.1 EndoArt Artificial Endothelial Layer: Eye-yon Medical 50
9.1.1 Product Description 50
9.1.2 Research and Development 50
9.2 Retinal Implant System (IRIS): Intelligent Medical Implants 51
9.2.1 Product Description 51
9.2.2 Research and Development 51
10. MARKET INSIGHTS BY MATERIAL TYPE 52
10.1 General Overview 52
10.1.1 Fiber Artificial Iris 54
10.1.1.1 Case Study: Comparison of complication rate for artificial iris with or without mesh 55
10.1.2 Fiber-free Artificial Iris 56
11. MARKET INSIGHTS BY COLOUR 58
11.1 General Overview 58
11.1.1 Blue Colour Artificial Iris 60
11.1.2 Brown Colour Artificial Iris 61
11.1.3 Other Colour Artificial Iris 61
12. MARKET INSIGHTS BY APPLICATION 63
12.1 General Overview 63
12.1.1 Cosmetic Application 64
12.1.2 Therapeutic Application 65
13. MARKET INSIGHTS BY AGE GROUP 67
13.1 General Overview 67
13.1.1 Pediatric 68
13.1.2 Adults 71
14. MARKET INSIGHTS BY END-USERS 73
14.1 General Overview 73
14.1.1 Hospitals 74
14.1.2 Eye Surgery Centers 75
14.1.3 Others Eye Care Facility 77
15. MARKET INSIGHTS BY REGION 78
15.1 General Overview 78
15.2 North America Artificial Iris Market (2018-2025) 80
15.2.1 North America Artificial Iris Market by Material Type 80
15.2.2 North America Artificial Iris Market by Colour 81
15.2.3 North America Artificial Iris Market by Application 81
15.2.4 North America Artificial Iris Market by Age Group 82
15.2.5 North America Artificial Iris Market by End-User 82
15.2.6 North America Artificial Iris Market by Country 83
15.2.6.1 United States Artificial Iris Market (2018-2025) 83
15.2.6.1.1 Eye Health Statistics, US 84
15.2.6.1.2 US Health Spending by Type of Service or Product, 2017 85
15.2.6.1.3 Health Spending by Major Sources of Funds 87
15.2.6.1.4 US Artificial Iris Market by Material Type 88
15.2.6.1.5 US Artificial Iris Market by Colour 88
15.2.6.1.6 US Artificial Iris Market by Application 89
15.2.6.1.7 US Artificial Iris Market by Age Group 89
15.2.6.1.8 US Artificial Iris Market by End-User 90
15.2.6.2 Canada Artificial Iris Market (2018-2025) 90
15.2.6.2.1 The Prevalence of Canadian Vision Loss and Cataract Surgery 90
15.2.6.2.2 Key Findings on Canada Healthcare Spending, 2018 92
15.2.6.2.3 Key Findings on Hospital sector Spending in Canada, 2017 93
15.2.6.2.4 Canadian Population Projection 94
15.2.6.2.5 Canada Artificial Iris Market by Material Type 94
15.2.6.2.6 Canada Artificial Iris Market by Colour 95
15.2.6.2.7 Canada Artificial Iris Market by Application 95
15.2.6.2.8 Canada Artificial Iris Market by Age Group 96
15.2.6.2.9 Canada Artificial Iris Market by End-User 96
15.2.6.3 Rest of North America Artificial Iris market (2018-2025) 97
15.2.6.3.1 Rest of North America Artificial Iris Market by Material Type 98
15.2.6.3.2 Rest of North America Artificial Iris Market by Colour 99
15.2.6.3.3 Rest of North America Artificial Iris Market by Application 99
15.2.6.3.4 Rest of North America Artificial Iris Market by Age Group 100
15.2.6.3.5 Rest of North America Artificial Iris Market by End-User 100
15.3 Europe Artificial Iris Market (2018-2025) 101
15.3.1 Europe Artificial Iris Market by Material Type 101
15.3.2 Europe Artificial Iris Market by Colour 102
15.3.3 Europe Artificial Iris Market by Application 102
15.3.4 Europe Artificial Iris Market by Age Group 103
15.3.5 Europe Artificial Iris Market by End-User 103
15.3.6 Europe Artificial Iris Market by Country 104
15.3.6.1 Germany Artificial Iris Market (2018-2025) 104
15.3.6.1.1 Germany Artificial Iris Market by Material Type 105
15.3.6.1.2 Germany Artificial Iris Market by Colour 106
15.3.6.1.3 Germany Artificial Iris Market by Application 106
15.3.6.1.4 Germany Artificial Iris Market by Age Group 107
15.3.6.1.5 Germany Artificial Iris Market by End-User 107
15.3.6.2 Netherlands Artificial Iris Market (2018-2025) 108
15.3.6.2.1 Netherlands Artificial Iris Market by Material Type 108
15.3.6.2.2 Netherlands Artificial Iris Market by Colour 109
15.3.6.2.3 Netherlands Artificial Iris Market by Application 109
15.3.6.2.4 Netherlands Artificial Iris Market by Age Group 110
15.3.6.2.5 Netherlands Artificial Iris Market by End-User 110
15.3.6.3 Rest of Europe Artificial Iris Market (2018-2025) 111
15.3.6.3.1 Rest of Europe Artificial Iris Market by Material Type 111
15.3.6.3.2 Rest of Europe Artificial Iris Market by Colour 111
15.3.6.3.3 Rest of Europe Artificial Iris Market by Application 112
15.3.6.3.4 Rest of Europe Artificial Iris Market by Age Group 112
15.3.6.3.5 Rest of Europe Artificial Iris Market by End-User 113
15.4 Asia Pacific Artificial Iris Market (2018-2025) 113
15.4.1 Asia-Pacific Artificial Iris Market by Material Type 115
15.4.2 Asia-Pacific Artificial Iris Market by Colour 115
15.4.3 Asia-Pacific Artificial Iris Market by Application 116
15.4.4 Asia-Pacific Artificial Iris Market by Age Group 116
15.4.5 Asia-Pacific Artificial Iris Market by End-User 117
15.4.6 Asia Pacific Artificial Iris Market by Country 117
15.4.6.1 Japan Artificial Iris Market (2018-2025) 118
15.4.6.1.1 Japan Artificial Iris Market by Material Type 119
15.4.6.1.2 Japan Artificial Iris Market by Colour 119
15.4.6.1.3 Japan Artificial Iris Market by Application 120
15.4.6.1.4 Japan Artificial Iris Market by Age Group 120
15.4.6.1.5 Japan Artificial Iris Market by End-User 121
15.4.6.2 China Artificial Iris Market (2018-2025) 121
15.4.6.2.1 China Artificial Iris Market by Material Type 122
15.4.6.2.2 China Artificial Iris Market by Colour 123
15.4.6.2.3 China Artificial Iris Market by Application 123
15.4.6.2.4 China Artificial Iris Market by Age Group 124
15.4.6.2.5 U China S Artificial Iris Market by End-User 124
15.4.6.3 India Artificial Iris Market (2018-2025) 125
15.4.6.3.1 India Artificial Iris Market by Material Type 125
15.4.6.3.2 India Artificial Iris Market by Colour 126
15.4.6.3.3 India Artificial Iris Market by Application 126
15.4.6.3.4 India Artificial Iris Market by Age Group 127
15.4.6.3.5 India Artificial Iris Market by End-User 127
15.4.6.4 Rest of APAC Artificial Iris Market (2018-2025) 128
15.4.6.4.1 Rest of APAC Artificial Iris Market by Material Type 129
15.4.6.4.2 Rest of APAC Artificial Iris Market by Colour 130
15.4.6.4.3 Rest of APAC Artificial Iris Market by Application 130
15.4.6.4.4 Rest of APAC Artificial Iris Market by Age Group 131
15.4.6.4.5 Rest of APAC Artificial Iris Market by End-User 131
15.5 Rest of World Artificial Iris Market (2018-2025) 132
15.5.1 ROW Artificial Iris Market by Material Type 133
15.5.2 ROW Artificial Iris Market by Colour 134
15.5.3 ROW Artificial Iris Market by Application 134
15.5.4 ROW Artificial Iris Market by Age Group 135
15.5.5 ROW Artificial Iris Market by End-User 135
16. COMPETITIVE SCENARIO 136
16.1 Porter’s Five forces analysis 136
16.1.1 Bargaining power of Supplier 137
16.1.2 Bargaining power of Buyer 137
16.1.3 Industry Rivalry 137
16.1.4 Availability of Substitute 137
16.1.5 Threat of new Entrants 138
17. TOP COMPANY PROFILES 139
17.1 Morcher 139
17.1.1 Key Facts 139
17.1.2 Business Description 139
17.1.3 Key Product/Services Offerings 139
17.1.4 Growth Strategy 142
17.2 Ophtec 144
17.2.1 Key Facts 144
17.2.2 Business Description 144
17.2.3 Key Product/Services Offerings 145
17.2.4 Growth Strategy 147
17.2.5 SWOT Analysis 147
17.2.6 Recent Developments 148
17.2.6.1 Partnerships (Strategic Alliance) 148
17.2.6.2 Business Expansion 148
17.3 HumanOptics 149
17.3.1 Key Facts 149
17.3.2 Business Description 149
17.3.3 Key Product/Services Offerings 149
17.3.4 Growth Strategy 150
17.3.5 SWOT Analysis 150
17.4 Reper NN 151
17.4.1 Key Facts 151
17.4.2 Business Description 151
17.4.3 Key Product/Services Offerings 151
17.5 VEO Ophthalmics 152
17.5.1 Key Facts 152
17.5.2 Business Description 152
17.5.3 Key Product/Services Offerings 152
17.5.4 Recent Developments 153
17.5.4.1 Product Launches 153
17.5.4.2 Partnership 153
17.6 Spectrum Surgical 154
17.6.1 Key Facts 154
17.6.2 Business Description 154
17.6.3 Key Product/Services Offerings 155
17.6.4 Growth Strategy 156
17.7 EyeYon Medical 157
17.7.1 Key Facts 157
17.7.2 Business Description 157
17.7.3 Key Product/Services Offerings 157
17.7.4 Growth Strategy 157
17.8 Pixium Vision 159
17.8.1 Key Facts 159
17.8.2 Business Description 160
17.8.3 Key Product/Services Offerings 160
17.8.4 Growth Strategy 160
17.8.5 SWOT Analysis 162
17.8.6 Key Financials 163
17.8.7 Recent Developments 164
17.8.7.1 Product Launches 164
TABLE 2 Aniridia and Other Iris Malformations 32
TABLE 3 Top Country with Current and Projected Per Capita Healthcare Spending and GDP Share (%) 34
TABLE 4 Global Top 10 Most Health-Conscious Country 2018 34
TABLE 5 The 6 Artificial Iris Implantation Techniques 41
TABLE 6 Key Facts on Prevalence of Common Eye Disorder 46
TABLE 7 Top Product Launches 47
TABLE 8 Top Partnerships 47
TABLE 9 Top Business Expansion & Investment 47
TABLE 10 Clinical Description: EndoArt 49
TABLE 11 Clinical Description: IRIS 50
TABLE 12 Device Models and Colours in All Eyes Treated with the Custom Flex Artificial Iris by Paediatric and Adult Cohorts 52
TABLE 13 Comparison of complication rate for artificial iris with or without mesh 54
TABLE 14 Eye Colour Statistics from Most Common to Most Rare 58
TABLE 15 Device Models and Colours in All Eyes Treated with the CustomFlex Artificial Iris by Pediatric and Adult Cohorts 58
TABLE 16 Device Models and Colours in All Eyes Treated with the CustomFlex Artificial Iris by Paediatric and Adult Cohorts 66
TABLE 17 Specific Eye Problems in Pediatric 68
TABLE 18 Total number & number/100,000 population of Ophthalmologists by province, 2018 90
TABLE 19 Canadian Population Projection, by Age Group (in ‘000) 93
TABLE 20 Morcher Key Facts 138
TABLE 21 Product segmentation of Asahi Kasei Corporation 138
TABLE 22 Morcher Growth Strategy 141
TABLE 23 Ophtec Key Facts 143
TABLE 24 Product segmentation of Ophtec 144
TABLE 25 Ophtec Growth Strategy 146
TABLE 26 Ophtec BV Partnerships (Strategic Alliance) 147
TABLE 27 Ophtec BV Business Expansion 147
TABLE 28 HumanOptics Key Facts 148
TABLE 29 Product segmentation of Humanoptics 148
TABLE 30 Biotricity Growth Strategy 149
TABLE 31 Reper NN Key Facts 150
TABLE 32 Product segmentation of Comarch 150
TABLE 33 BrightOcular Key Facts 151
TABLE 34 Product segmentation of Hill-Rom Holdings Inc 151
TABLE 35 VEO Ophthalmics Inc Product Launches 152
TABLE 36 VEO Ophthalmics Partnership 152
TABLE 37 Spectrum Surgical Key Facts 153
TABLE 38 Product segmentation of Spectrum Surgical 154
TABLE 39 Infobionic Growth Strategy 155
TABLE 40 EyeYon Medical Key Facts 156
TABLE 41 Product segmentation of EyeYon Medical 156
TABLE 42 EyeYon Medical Growth Strategy 156
TABLE 43 EyeYon Medical Business Expansions and Investment 157
TABLE 44 Pixium Vision Key Facts 158
TABLE 45 Pixium Vision Ownership Structure 158
TABLE 46 Product segmentation of Pixium Vision 159
TABLE 47 Pixium Vision Growth Strategy 159
TABLE 48 Pixium Vision Product Launches 163
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
